CNE000000C82
CNE000000C82
SHANGHAI PHARMACEUTICALS HOLDIN
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 61.86B EUR | 57.11B EUR | 63.23B EUR | 66.23B EUR |
Enterprise Value | 89.21B EUR | 73.52B EUR | 85.61B EUR | 85.8B EUR |
Valuation Multiples | ||||
Trailing P/E | 12.73x | 13.99x | 12.35x | 13.15x |
Forward P/E | 10.21x | -- | -- | -- |
Price to Sales | 0.21x | 0.26x | 0.29x | 0.32x |
Price to Book | 0.79x | 0.73x | 0.82x | 0.87x |
EV/Revenue | 0.31x | 0.34x | 0.4x | 0.41x |
EV/EBITDA | 8.15x | 6.67x | 6.66x | 8.63x |
Price to FCF (P/FCF) | 48.62x | 8.79x | 15.08x | 22.41x |
EV/FCF | 70.12x | 11.31x | 20.42x | 29.03x |
FCF Yield | 2.06% | 11.38% | 6.63% | 4.46% |